MSC

MSC. Mesenchymal stem cells, also commonly referred to as mesenchymal stromal cells, are a type of multipotent adult stem cell first identified in the bone marrow. They possess the capacity to differentiate into a variety of cell types, including osteoblasts, chondrocytes, and adipocytes, making them a cornerstone of regenerative medicine. Their therapeutic potential is further amplified by potent immunomodulatory and anti-inflammatory properties, which are mediated through the secretion of bioactive molecules and direct cell-to-cell contact. Research into these cells spans numerous clinical fields, from orthopedic surgery to the treatment of graft-versus-host disease.

● Definition and Overview

The modern definition of MSC, established by the International Society for Cellular Therapy, includes three minimal criteria: plastic-adherence under standard culture conditions, specific surface antigen expression, and multipotent differentiation potential *in vitro*. These cells were first isolated and characterized from bone marrow by Alexander Friedenstein and colleagues, who noted their fibroblast-like morphology and colony-forming ability. While the bone marrow remains a primary source, MSCs have since been identified in nearly every connective tissue, including adipose tissue, umbilical cord, and dental pulp. Their discovery has significantly advanced the field of cell therapy, offering a promising alternative to embryonic stem cells due to fewer ethical concerns and a favorable safety profile.

● Types and Classification

MSCs are broadly classified based on their tissue of origin, with each source conferring slight variations in properties and yield. The most studied type is **bone marrow-derived MSC**, harvested via aspiration from sites like the iliac crest. **Adipose-derived MSC** is obtained from liposuction procedures and is abundant and easily accessible. **Perinatal tissue-derived MSCs** include cells from the Wharton's jelly of the umbilical cord, amniotic fluid, and placenta, which are considered immunologically naive. Other notable types include **dental pulp-derived MSC** from tooth structures and **synovial membrane-derived MSC** from joint linings. Classification also considers their immunophenotype, typically positive for markers like CD73, CD90, and CD105, and negative for CD34, CD45, and HLA-DR.

● Biological Functions and Mechanisms

The primary biological functions of MSCs are tissue repair and immunomodulation. Their differentiation capacity supports the regeneration of bone, cartilage, muscle, and tendon. Crucially, they exert immunomodulatory effects by suppressing the proliferation and function of immune cells such as T cells, B cells, natural killer cells, and dendritic cells. These mechanisms are largely paracrine, mediated by the secretion of exosomes, growth factors, chemokines, and cytokines like TGF-β, PGE2, and IDO. They also engage in direct contact with immune cells via molecules like PD-L1. Furthermore, MSCs exhibit homing capabilities, migrating to sites of injury or inflammation in response to signals like SDF-1.

● Clinical and Therapeutic Applications

MSCs have entered clinical trials for a vast array of conditions. In orthopedics, they are investigated for treating osteoarthritis, meniscus tears, and bone fracture non-unions. Their immunomodulatory power is harnessed for autoimmune diseases, including Crohn's disease, multiple sclerosis, and, most notably, steroid-refractory graft-versus-host disease following bone marrow transplantation. Cardiovascular applications focus on myocardial infarction and heart failure, aiming to improve cardiac function. Other promising areas include acute respiratory distress syndrome (as seen in COVID-19), liver cirrhosis, and spinal cord injury. Most therapies involve either direct local implantation or systemic intravenous infusion.

● Research and Development

Current research is intensely focused on overcoming limitations such as low *in vivo* survival, inconsistent therapeutic outcomes, and donor variability. Strategies include genetic engineering to enhance homing or secretion of therapeutic factors, and the use of biomaterial scaffolds to improve cell retention and differentiation. The therapeutic role of MSC-derived exosomes as a cell-free alternative is a major area of investigation. Large-scale manufacturing under Good Manufacturing Practice standards is critical for clinical translation, involving bioreactors and defined culture media. Ongoing debates in the field concern their true *in vivo* identity, the risk of malignant transformation, and the standardization of potency assays to predict clinical efficacy.

Category:Stem cells Category:Regenerative medicine Category:Cell biology